EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Clinical significance of gross morphological type beyond tumor burden in hepatocellular carcinoma treated with atezolizumab plus bevacizumab

Seonjeong Woo, Donghyeon Kim, Chansik An, Sanghoon Jung, Su Jin Jang, Won Suk Lee, Hong Jae Chon

Clinical and Molecular Hepatology · 01.10.2026 · 32 (4) · e2026.0866

DOI: 10.3350/cmh.2026.0866 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Molecular Hepatology, erschienen am 01.10.2026. Verfasst von Seonjeong Woo und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Life Science, CHA University, Seongnam, Korea. Die Arbeit nennt 8 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: National Research Foundation of Korea, Ministry of Science and ICT, Roche.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

Gross morphological typeHepatocellular carcinomaImmunotherapyInfiltrative morphology

Autor:innen und Institutionen

  • Department of Life Science, CHA University, Seongnam, Korea.
  • Department of Medical Oncology, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam, Korea.
  • Department of Radiology, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam, Korea.
  • Department of Nuclear Medicine, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam, Korea.
  • Department of Medical Oncology, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam, Korea. minidoctor@cha.ac.kr.

Förderung

  • National Research Foundation of Korea
  • Ministry of Science and ICT
  • Roche
  • BeOne Medicines
  • IMBDx
  • Dong-A ST
  • Boryung

Zitieren

APA

Woo, S., Kim, D., An, C., Jung, S., Jang, S. J., Lee, W. S., & Chon, H. J. (2026). Clinical significance of gross morphological type beyond tumor burden in hepatocellular carcinoma treated with atezolizumab plus bevacizumab. Clinical and Molecular Hepatology, 32(4), e2026.0866. https://doi.org/10.3350/cmh.2026.0866

Vancouver

Woo S, Kim D, An C, Jung S, Jang SJ, Lee WS, et al. Clinical significance of gross morphological type beyond tumor burden in hepatocellular carcinoma treated with atezolizumab plus bevacizumab. Clinical and Molecular Hepatology. 2026;32(4):e2026.0866. doi:10.3350/cmh.2026.0866

BibTeX
@article{Woo2026,
  author = {Woo, Seonjeong and Kim, Donghyeon and An, Chansik and Jung, Sanghoon and Jang, Su Jin and Lee, Won Suk and Chon, Hong Jae},
  title = {Clinical significance of gross morphological type beyond tumor burden in hepatocellular carcinoma treated with atezolizumab plus bevacizumab},
  journal = {Clinical and Molecular Hepatology},
  year = {2026},
  volume = {32},
  number = {4},
  pages = {e2026.0866},
  doi = {10.3350/cmh.2026.0866}
}
Kostenlos starten →